Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 3/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28159724 | 0.85 | CES1 (0.39) | FAAHMEN1TP53CYP1A2CYP3A4 | |
| SCHEMBL2505681 | 0.85 | GRIK1 (0.38) | FAAHMEN1TP53CYP1A2CYP3A4 | |
| SCHEMBL2502247 | 0.85 | CES1 (0.39) | FAAHMEN1TP53CYP1A2CYP3A4 | |
| SCHEMBL1042978 | 0.75 | GRIK1 (0.34) | FAAHMEN1TP53CYP1A2CYP3A4 | |
| SCHEMBL2210988 | 0.75 | LMNA (0.37) | — | |
| SCHEMBL736602 | 0.75 | LMNA (0.37) | — | |
| SCHEMBL4978414 | 0.74 | GRIK1 (0.37) | FAAHMEN1TP53CYP1A2CYP3A4 | |
| SCHEMBL4977299 | 0.74 | CA12 (0.42) | FAAHMEN1TP53CYP1A2CYP3A4 | |
| SCHEMBL10423554 | 0.74 | CES1 (0.38) | FAAHMEN1TP53CYP1A2CYP3A4 | |
| SCHEMBL6450874 | 0.74 | CA1 (0.42) | FAAHMEN1TP53CYP1A2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020120086-A1 | Quaternary polymers with functional amine groups field of the invention | BAYER AKTIENGESELLSCHAFT (DE) | 2002-08-29 | — | — | US | disclosed |